Why is Lotus Eye Hospit falling/rising?

As of 29-Jul, Lotus Eye Hospital & Institute Ltd is currently priced at 74.40, reflecting an increase of 1.63 or 2.24%. Despite this uptick, the stock has been underperforming recently, having fallen consecutively for the last two days with a total decline of 1.64%. The stock's performance today has also lagged behind its sector by 0.85%. Over the past week, it has decreased by 1.89%, although it has shown a positive return of 4.74% over the last month. The company maintains a low debt-to-equity ratio, which is a positive factor, but the majority of its shareholders are non-institutional, which may influence stock stability and investor confidence.
In the broader market context, the stock's recent performance contrasts with the benchmark Sensex, which has declined by only 1.03% over the past week. While Lotus Eye Hospital has outperformed the Sensex over the longer term, with an 8.09% year-to-date return compared to the benchmark's 4.09%, the short-term underperformance may be affecting investor sentiment. Additionally, the rising investor participation, indicated by a 44.58% increase in delivery volume, suggests that there is still interest in the stock, which could help stabilize its price in the near future.